Post-approval studies (Phase 4)Study completedNCT00142987
What this trial is testing
Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS
Who this might be right for
IBS-C and IBS With Mixed Bowel Habits
Novartis 664